Robert E. Hobbs

Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy

Chimerism of the Transplanted Heart

Long-Term Trends in the Incidence of and Survival with Heart Failure

Mechanisms of Thrombus Formation

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

Prosthetic-Joint Infections

Implantable Left Ventricular Assist Devices

The Failing Heart — An Engine Out of Fuel

The Myth of the “Vulnerable Plaque”

Macrophages in the Pathogenesis of Atherosclerosis

Calcineurin Promotes Hypoxia-inducible Factor 1α Expression by Dephosphorylating RACK1 and Blocking RACK1 Dimerization

Quantification of coronary artery calcium using ultrafast computed tomography

Cytomegalovirus and Lung Transplantation

The changing landscape of atherosclerosis

The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure

Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis

Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention

Anesthesiology

Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary β2-adrenergic receptor gene delivery

Racial differences in coronary calcium prevalence among high-risk adults

Cardiovascular Toxicities of Immunosuppressive Agents

A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure

Effect of Carvedilol on Survival in Severe Chronic Heart Failure

Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C

Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study

Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients

Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device⁎⁎Thoratec Corporation, Pleasanton, Calif.

Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay

A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1

Echocardiographic findings in fulminant and acute myocarditis

Multicenter Intravascular Ultrasound Validation Study Among Heart Transplant Recipients

Some Thoughts on the Vasculopathy of Women With Ischemic Heart Disease

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

Heart failure

Inflammation in atherosclerosis

Myocarditis

Costimulation Blockade with Belatacept in Renal Transplantation

A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes

Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation

Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups

Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

Preoperative clinical assessment and dipyridamole thallium-201 scintigraphy for prediction and prevention of cardiac events in patients having major noncardiovascular surgery and known or suspected coronary artery disease

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation

Inflammation, Atherosclerosis, and Coronary Artery Disease

Regulation of cardiac hypertrophy by intracellular signalling pathways

Infection in Solid-Organ Transplant Recipients

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Immunosuppressive Drugs for Kidney Transplantation

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

Treatment of Infections Associated with Surgical Implants

Congenital coronary artery anomalies: a bridge from embryology to anatomy and pathophysiology—a position statement of the development, anatomy, and pathology ESC Working Group

Myocarditis

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

Stability and Instability: Two Faces of Coronary Atherosclerosis

HIF-1α is required for development of the sympathetic nervous system

Myocarditis

ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease

Mechanical Circulatory Support and Cardiac Transplantation

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary

On the Failure of the Bootstrap for Matching Estimators

Our Preoccupation With Coronary Luminology

Evidence Mandating Earlier and More Aggressive Treatment of Hypercholesterolemia

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device

Nonvalvular Cardiovascular Device–Related Infections

Q Wave and Non-Q Wave Myocarditis with Special Reference to Clinical Significance.

Intracoronary Adenovirus-Mediated Delivery and Overexpression of the β ₂ -Adrenergic Receptor in the Heart

Fine-Particulate Air Pollution and Life Expectancy in the United States

Regression of Cellular Hypertrophy After Left Ventricular Assist Device Support

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Coronary artery anomalies in 126,595 patients undergoing coronary arteriography

Use of Digital Subtraction Fluorography in Screening for Coronary Artery Disease in Patients With Chronic Renal Failure

INEFFECTIVENESS OF DIPYRIDAMOLE SPECT THALLIUM IMAGING AS A SCREENING TECHNIQUE FOR CORONARY ARTERY DISEASE IN PATIENTS WITH END-STAGE RENAL FAILURE

Dichotomous pattern of coronary atherosclerosis 1 to 9 years after transplantation: Insights from systematic intravascular ultrasound imaging

Implantable LVAD infections: Implications for permanent use of the device

One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology

Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study

Impact of Donor Spontaneous Intracranial Hemorrhage on Outcome after Heart Transplantation

Hemodynamic and physiologic changes during support with an implantable left ventricular assist device

High or low doses of ACE inhibitors for heart failure?

Donor or Recipient Hepatitis B Seropositivity Is Associated With Allograft Vasculopathy

Guidelines for the Diagnosis and Management of Heart Failure

Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation Results of a prospective, randomized multicenter trial

Peritransplant Ischemic Injury Is Associated With Up-Regulation of Stromal Cell-Derived Factor-1

Left ventricular diastolic dysfunction in lymphocytic myocarditis as assessed by Doppler echocardiography

Occult and Frequent Transmission of Atherosclerotic Coronary Disease With Cardiac Transplantation

Infection after heart transplantation: a multiinstitutional study. Cardiac Transplant Research Database Group.

Effect of the Implantable Left Ventricular Assist Device on Neuroendocrine Activation in Heart Failure

Novel Strategies for the Management of Acute Decompensated Heart Failure

Comparison of stress digital ventriculography, stress thallium scintigraphy, and digital fluoroscopy in the diagnosis of coronary artery disease in subjects without prior myocardial infarction

Cardiac cinefluoroscopy as an inexpensive aid in the diagnosis of coronary artery disease

Lymphocytic myocarditis and dilated cardiomyopathy: treatment with immunosuppressive agents

Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.

Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection

High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults

Development of Transplantation Vasculopathy and Progression of Donor-Transmitted Atherosclerosis